Document is current

Any future updates will be listed below

Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2

Crossref DOI link: https://doi.org/10.1007/s00280-016-3046-2

Published Online: 2016-05-04

Published Print: 2016-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark